MedTrace Logo

Effectiveness of Slip Resistant Footwear in Dairy Industry

NCT07280988 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2025-12-15

No results posted yet for this study

Summary

In the dairy industry, same-level falls are a major problem and a well-known challenge. At Arla's dairy in Taulov, where this RCT study is being carried out, reports of risk observations, near incidents, and workplace accidents have increased over the past five years. Accident statistics further show that same-level falls are the most common incidents, with slippery floors and surfaces being by far the main cause of both near incidents and risk observations. Because of this, it is necessary to test different types of safety footwear that, based on laboratory studies, are considered particularly suitable for the working environment in a dairy.

it is hypothesized that employees, through subjective questionnaires, will rate one shoe as less slippery than the other. At the same time, it is hypothesized that employees will also subjectively find one shoe more comfortable than the other.

Conditions

  • Slips
  • Falls Prevention
  • Perceived Slipperiness

Interventions

DEVICE

Environment specific safety footwear

The participants will wear two different safety shoes (SIKA Highline and AIRTOX FW44) in the test periode (20 working days). 10 working days in each safety shoes.

Sponsors & Collaborators

  • Herning Hospital

    collaborator OTHER

  • Sika footwear

    collaborator UNKNOWN

  • billigarbejdstøoj.dk

    collaborator UNKNOWN

  • Arla Foods

    collaborator INDUSTRY

  • Aalborg University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2025-12-10
Completion
2025-12-10

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07280988 on ClinicalTrials.gov